- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1375
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1375 companies
Pacira BioSciences
Market Cap: US$1.2b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$25.65
7D
-3.8%
1Y
79.0%
BioGaia
Market Cap: SEK 11.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 109.40
7D
3.6%
1Y
-3.5%
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.73
7D
-0.2%
1Y
-10.3%
BioLife Solutions
Market Cap: US$1.2b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$24.18
7D
-8.0%
1Y
0.04%
Precigen
Market Cap: US$1.2b
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$3.49
7D
-8.3%
1Y
282.0%
Enliven Therapeutics
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$18.57
7D
-6.8%
1Y
-23.0%
Wuhan Keqian BiologyLtd
Market Cap: CN¥8.1b
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
688526
CN¥17.52
7D
-3.1%
1Y
29.8%
Hanall Biopharma
Market Cap: ₩1.6t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩30,600.00
7D
-6.6%
1Y
-18.4%
Daewoong Pharmaceutical
Market Cap: ₩1.6t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩132,500.00
7D
-6.4%
1Y
-3.3%
SSY Group
Market Cap: HK$8.7b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.90
7D
-2.0%
1Y
-28.7%
Nuvation Bio
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$3.01
7D
-5.0%
1Y
21.9%
Collegium Pharmaceutical
Market Cap: US$1.1b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$34.65
7D
-4.2%
1Y
-9.9%
GC Biopharma
Market Cap: ₩1.6t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩131,600.00
7D
-5.3%
1Y
-13.0%
Kuros Biosciences
Market Cap: CHF 878.1m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.74
7D
-4.1%
1Y
22.8%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥7.8b
Provides in-vitro diagnostics products and services in the People’s Republic of China and internationally.
300406
CN¥13.38
7D
-0.9%
1Y
0.6%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥7.8b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥66.66
7D
-13.4%
1Y
83.7%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.7b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.30
7D
0.8%
1Y
4.4%
Northeast Pharmaceutical Group
Market Cap: CN¥7.6b
Engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China.
000597
CN¥5.32
7D
-3.3%
1Y
16.4%
Guizhou Bailing Group Pharmaceutical
Market Cap: CN¥7.5b
Guizhou Bailing Group Pharmaceutical Co., Ltd.
002424
CN¥5.42
7D
-4.1%
1Y
51.0%
L&C BIOLTD
Market Cap: ₩1.5t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩50,200.00
7D
-7.6%
1Y
152.9%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.98
7D
-2.4%
1Y
23.5%
Wedge IndustrialLtd
Market Cap: CN¥7.5b
Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.
000534
CN¥15.42
7D
-0.8%
1Y
48.6%
Vetoquinol
Market Cap: €898.8m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
VETO
€76.20
7D
-2.8%
1Y
-10.7%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.4b
Engages in the pharmaceutical business in China.
000915
CN¥31.55
7D
-2.0%
1Y
6.8%
Shandong Boan Biotechnology
Market Cap: HK$8.1b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$12.54
7D
-10.2%
1Y
29.3%
Gubra
Market Cap: DKK 6.5b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 399.60
7D
-5.9%
1Y
-20.1%
Pharming Group
Market Cap: €872.2m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.27
7D
7.1%
1Y
79.0%
Shanghai OPM Biosciences
Market Cap: CN¥7.1b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥66.17
7D
23.9%
1Y
122.8%
Jiangsu Jibeier Pharmaceutical
Market Cap: CN¥7.1b
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
688566
CN¥35.40
7D
-1.8%
1Y
60.9%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.1b
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
002437
CN¥3.11
7D
-7.4%
1Y
51.0%
PolyPeptide Group
Market Cap: CHF 791.8m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 24.00
7D
-8.0%
1Y
-24.1%
Maccura BiotechnologyLtd
Market Cap: CN¥7.0b
Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.
300463
CN¥11.57
7D
-1.8%
1Y
-10.0%
Towa Pharmaceutical
Market Cap: JP¥146.9b
Manufactures and sale ethical drugs in Japan.
4553
JP¥3,000.00
7D
0.9%
1Y
-2.1%
Shanghai InnoStar Bio-tech
Market Cap: CN¥7.0b
Provides drug research and development services in China and internationally.
688710
CN¥47.39
7D
-3.6%
1Y
78.1%
Kaken Pharmaceutical
Market Cap: JP¥144.8b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,855.00
7D
-0.1%
1Y
0.2%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.81
7D
-2.1%
1Y
2.4%